What's in Prothena Biosciences Ltd.'s pipeline?

Prothena Biosciences Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Prothena Biosciences Ltd.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Associazione Italiana per lo Studio del Pancreas, BeiGene, Beijing Biostar Pharmaceuticals Co., Ltd., Delcath Systems Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/prothena-biosciences-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Prothena Biosciences Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prothena Biosciences Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Standard of Care Chemotherapy	Standard of Care Chemotherapy	phase 3	Chemotherapy		Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Associazione Italiana per lo Studio del Pancreas · 1 shared drug class
BeiGene · 1 shared drug class
Beijing Biostar Pharmaceuticals Co., Ltd. · 1 shared drug class
Delcath Systems Inc. · 1 shared drug class
Ludwig-Maximilians - University of Munich · 1 shared drug class
Prof. Dr. med. Claus Rödel · 1 shared drug class
Seoul National University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Prothena Biosciences Ltd.:

Cite this brief

Drug Landscape (2026). Prothena Biosciences Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/prothena-biosciences-ltd. Accessed 2026-06-10.